High expression of ABCG2 induced by EZH2 disruption has pivotal roles in MDS pathogenesis Journal Article


Authors: Kawabata, K. C.; Hayashi, Y.; Inoue, D.; Meguro, H.; Sakurai, H.; Fukuyama, T.; Tanaka, Y.; Asada, S.; Fukushima, T.; Nagase, R.; Takeda, R.; Harada, Y.; Kitaura, J.; Goyama, S.; Harada, H.; Aburatani, H.; Kitamura, T.
Article Title: High expression of ABCG2 induced by EZH2 disruption has pivotal roles in MDS pathogenesis
Abstract: Both proto-oncogenic and tumor-suppressive functions have been reported for enhancer of zeste homolog 2 (EZH2). To investigate the effects of its inactivation, a mutant EZH2 lacking its catalytic domain was prepared (EZH2-dSET). In a mouse bone marrow transplant model, EZH2-dSET expression in bone marrow cells induced a myelodysplastic syndrome (MDS)-like disease in transplanted mice. Analysis of these mice identified Abcg2 as a direct target of EZH2. Intriguingly, Abcg2 expression alone induced the same disease in the transplanted mice, where stemness genes were enriched. Interestingly, ABCG2 expression is specifically high in MDS patients. The present results indicate that ABCG2 de-repression induced by EZH2 mutations have crucial roles in MDS pathogenesis.
Keywords: cancer cells; stem-cells; acute myeloid-leukemia; blast crisis; somatic mutations; hematopoietic; polycomb group proteins; myelodysplastic; syndromes; gene ezh2; histone methyltransferase ezh2; h3 lysine 27
Journal Title: Leukemia
Volume: 32
Issue: 2
ISSN: 0887-6924
Publisher: Nature Publishing Group  
Date Published: 2018-02-01
Start Page: 419
End Page: 428
Language: English
ACCESSION: WOS:000424517300019
DOI: 10.1038/leu.2017.227
PROVIDER: wos
PUBMED: 28720764
Notes: Article -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Daichi   Inoue
    27 Inoue